Skip to content

Clinical trials

Congenital Abnormalities trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Phase: Not applicable Country / region: France Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20091
20121
20143
20172
20182
20191
20201
20211
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Active, not recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Centre hospitalier de l'Université de Montréal (CHUM)2
Assistance Publique Hopitaux De Marseille1
Centre Psychothérapique de Nancy1
Céline PEBREL-RICHARD1
DePuy Orthopaedics1
European Organisation for Research and Treatment of Cancer - EORTC1
Institut Curie1
Institut National de la Santé Et de la Recherche Médicale, France1
Institut Paoli-Calmettes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities19
Cardiovascular Abnormalities3
Cardiovascular Diseases3
Aneurysm2
Arteriovenous Malformations2
Intracranial Hemorrhages2
Leukemia2
Leukemia, Myeloid, Acute2
Stroke2
Vascular Diseases2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.